Urologie (@Urologie) profile picture

https://teapawt.org/t.co/xJDVkPJ0Hy…

Heidelberg
Joined January 2009
Urologie retweeted
Semi-Live 2022 GLOBAL (March 2-5, 2022): Join wherever you are! State of the Art in Urologic Surgery: View, discuss, reflect, contemplate, chat and earn CME's! Limitless due to opportunity! Program and Registration: semi-live.org youtube.com/watch?v=KGmR6WO-…
Semi-Live 2022 GLOBAL (March 2-5, 2022): Join wherever you are! State of the Art in Urologic Surgery: View, discuss, reflect, contemplate, chat and earn CME's! Limitless due to opportunity! Program and Registration: semi-live.org youtube.com/watch?v=KGmR6WO-…
Invitation to “Semi-Live 2022” in Heidelberg! Registration is open! Early bird discount until December 15, 2021. All info here: semi-live.org/
Semi-Live March 2022 in Heidelberg
1
State-of-the-art staging of high risk prostate cancer for subsequent local therapy: replacement of CT and bone scan by PSMA-PET. thelancet.com/journals/lance…
Radiotherapy (RT) following radical prostatectomy: early salvage RT (PSA 0.2 ng/ml) vs.adjuvant RT reduces over-treatment by 50% with concomitant reduction of functional morbidities without compromising oncological safety. thelancet.com/journals/lanon…
RAVES or the end of adjuvant radiotherapy in high-risk prostate cancer: early salvage radiotherapy +/- equally effective if delivered at a PSA of < / = 0.2. PS: Indicate PSMA-PET in BCR! thelancet.com/pdfs/journals/…
TREXIT?: Needle track seeding of prostate cancer after transrectal prostate biopsy. reader.elsevier.com/reader/s…
RPx With vs. Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk PCa improved: event-free (e.g. death, progression, additional treatment), metastatic free, & overall survival. Did not improve 3-year biochemical progression-free survival. ascopubs.org/doi/pdf/10.1200…
Die Urologie in Zeiten von Corona | Mit Prof. Dr. Markus Hohenfellner | ... youtu.be/z-ywJvu1ruo via @YouTube
Similar pathways of compromized immunology in critical virus infections vs. critical cancers: a possible role of T cell - increased PD-1 expression. With a perspective of new indications for Checkpoint Inhibitors? Sattler, Kotsch et al. (Charité 2020) jci.org/articles/view/140965